1.   WHO Classification Of Tumors Editorial Board. Head and neck tumor. In WHO Classification of Tumor Series Volume 9, 5thed. Lyon: International Agency for Research on Cancer; 2024.

2.   Matsumoto Y, Mizoue K, Seto K. Atypical plexiform ameloblas- toma  with  dentinoid:  Adenoid  ameloblastoma  with  denti- noid. J Oral Pathol Med 2001;30(4):251–4.

3.   Ghasemi-Moridani  S,  Yazdi  I.  Adenoid  ameloblastoma  with dentinoid: A case report. Arch Iran Med 2008;11(1):110–2.

4.   Kessler HP. Intraosseous ameloblastoma. Oral Maxillofac Surg Clin North Am 2004;16(3):309–22.

5.   Xue J, Zhang W, Zhang J,  Bai J, Zhang A, Guo X, et al. Ade- noid   ameloblastoma   shares   clinicopathologic,    immuno- histochemical,  and  molecular  features  with  dentinogenic ghost cell tumor: A comparative analysis. Am J Surg Pathol 2023;47(11):1274–84.

6.   Coura  BP, Dos Santos JN, Fonseca FP, Bernardes VF, de Aqui- no  SN, Jorge Júnior J,  et  al. Adenoid  ameloblastoma with dentinoid   is   molecularly   different   from   ameloblastomas and  adenomatoid  odontogenic tumors. J  Oral  Pathol  Med 2021;50(10):1067–71.

7.   Bastos VC, Coura BP, Guimarães LM, Fernandes BG, Chan AC, Vargas PA, et al. Adenoid ameloblastoma harbors beta-caten- in mutations. Mod Pathol 2022;35(11):1562–69.

8.   Oh  KY,  Hong  SD,  Yoon  HJ.  Adenoid  ameloblastoma  shares clinical,  histologic,  and  molecular  features  with  dentino- genic  ghost  cell  tumor:  The   histologic  spectrum  of  WNT pathway-altered  benign  odontogenic  tumors.  Mod  Pathol 2023;36(3):100051.

9.    Oh KY, Kim JH, Yoon HJ. Calcifying odontogenic cyst demon- strates recurrent WNT pathway mutations and so-called ad- enoidameloblastoma-like histology: Evidence supporting its classification as a neoplasm. Mod Pathol 2024;37(6):100484.